Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC13394240;4241;4242 chr2:178779067;178779066;178779065chr2:179643794;179643793;179643792
N2AB13394240;4241;4242 chr2:178779067;178779066;178779065chr2:179643794;179643793;179643792
N2A13394240;4241;4242 chr2:178779067;178779066;178779065chr2:179643794;179643793;179643792
N2B12934102;4103;4104 chr2:178779067;178779066;178779065chr2:179643794;179643793;179643792
Novex-112934102;4103;4104 chr2:178779067;178779066;178779065chr2:179643794;179643793;179643792
Novex-212934102;4103;4104 chr2:178779067;178779066;178779065chr2:179643794;179643793;179643792
Novex-313394240;4241;4242 chr2:178779067;178779066;178779065chr2:179643794;179643793;179643792

Information

  • RefSeq wild type amino acid: M
  • RefSeq wild type transcript codon: ATG
  • RefSeq wild type template codon: TAC
  • Domain: Ig-5
  • Domain position: 49
  • Structural Position: 123
  • Q(SASA): 0.2727
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
M/I rs1561323191 None 0.012 N 0.126 0.235 0.434045841721 gnomAD-4.0.0 1.20032E-06 None None None None I None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
M/A 0.88 likely_pathogenic 0.8925 pathogenic -2.666 Highly Destabilizing 0.373 N 0.395 neutral None None None None I
M/C 0.9517 likely_pathogenic 0.9554 pathogenic -1.525 Destabilizing 0.996 D 0.539 neutral None None None None I
M/D 0.9948 likely_pathogenic 0.9952 pathogenic -1.314 Destabilizing 0.984 D 0.615 neutral None None None None I
M/E 0.943 likely_pathogenic 0.9494 pathogenic -1.221 Destabilizing 0.953 D 0.583 neutral None None None None I
M/F 0.6828 likely_pathogenic 0.7167 pathogenic -1.387 Destabilizing 0.742 D 0.495 neutral None None None None I
M/G 0.9698 likely_pathogenic 0.9738 pathogenic -3.05 Highly Destabilizing 0.854 D 0.588 neutral None None None None I
M/H 0.9641 likely_pathogenic 0.9718 pathogenic -2.135 Highly Destabilizing 0.996 D 0.573 neutral None None None None I
M/I 0.6592 likely_pathogenic 0.6961 pathogenic -1.601 Destabilizing 0.012 N 0.126 neutral N 0.399463836 None None I
M/K 0.8257 likely_pathogenic 0.8546 pathogenic -1.217 Destabilizing 0.815 D 0.513 neutral N 0.502714098 None None I
M/L 0.3756 ambiguous 0.4257 ambiguous -1.601 Destabilizing 0.078 N 0.241 neutral N 0.442104984 None None I
M/N 0.9618 likely_pathogenic 0.966 pathogenic -1.118 Destabilizing 0.984 D 0.587 neutral None None None None I
M/P 0.992 likely_pathogenic 0.993 pathogenic -1.935 Destabilizing 0.984 D 0.595 neutral None None None None I
M/Q 0.7966 likely_pathogenic 0.8208 pathogenic -1.107 Destabilizing 0.984 D 0.497 neutral None None None None I
M/R 0.8462 likely_pathogenic 0.8797 pathogenic -0.834 Destabilizing 0.939 D 0.563 neutral N 0.514895807 None None I
M/S 0.9352 likely_pathogenic 0.943 pathogenic -1.786 Destabilizing 0.742 D 0.465 neutral None None None None I
M/T 0.7631 likely_pathogenic 0.7952 pathogenic -1.577 Destabilizing 0.684 D 0.467 neutral N 0.486443687 None None I
M/V 0.2569 likely_benign 0.2886 benign -1.935 Destabilizing 0.003 N 0.109 neutral N 0.466329945 None None I
M/W 0.9411 likely_pathogenic 0.9529 pathogenic -1.338 Destabilizing 0.996 D 0.545 neutral None None None None I
M/Y 0.9295 likely_pathogenic 0.9417 pathogenic -1.474 Destabilizing 0.953 D 0.562 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.